| When tissue is an issue the liquid biopsy is nonissue: a review J Rodríguez, J Avila, C Rolfo, A Ruíz-Patiño, A Russo, L Ricaurte, ... Oncology and therapy 9 (1), 89-110, 2021 | 80 | 2021 |
| La plaga antonina A Ruiz-Patiño Medicina 42 (2), 175-181, 2020 | 76 | 2020 |
| Specificity and sensitivity of aquaporin 4 antibody detection tests in patients with neuromyelitis optica: a meta-analysis R Ruiz-Gaviria, I Baracaldo, C Castañeda, A Ruiz-Patiño, ... Multiple sclerosis and related disorders 4 (4), 345-349, 2015 | 76 | 2015 |
| EGFR exon 20 insertion in lung adenocarcinomas among Hispanics (geno1. 2-CLICaP) AF Cardona, L Rojas, ZL Zatarain-Barrón, HC Freitas, ST Granados, ... Lung Cancer 125, 265-272, 2018 | 67 | 2018 |
| Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non‐small cell lung cancer (NSCLC) compared with chemotherapy (Quijote‐CLICaP) A Ruiz‐Patiño, O Arrieta, AF Cardona, C Martín, LE Raez, ... Thoracic Cancer 11 (2), 353-361, 2020 | 64 | 2020 |
| Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutation AF Cardona, D Jaramillo-Velásquez, A Ruiz-Patiño, C Polo, E Jiménez, ... Journal of Neuro-Oncology 154 (3), 353-364, 2021 | 43 | 2021 |
| STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP) VCC de Lima, M Corassa, E Saldanha, H Freitas, O Arrieta, L Raez, ... Lung Cancer 170, 114-121, 2022 | 40 | 2022 |
| Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma AF Cardona, L Rojas, B Wills, L Bernal, A Ruiz-Patiño, O Arrieta, ... Journal of Neuro-Oncology 136 (2), 363-371, 2018 | 40 | 2018 |
| Bispecific antibodies in cancer immunotherapy: a novel response to an old question C Ordóñez-Reyes, JE Garcia-Robledo, DF Chamorro, A Mosquera, ... Pharmaceutics 14 (6), 1243, 2022 | 38 | 2022 |
| EGFR amplification and sensitizing mutations correlate with survival in lung adenocarcinoma patients treated with erlotinib (MutP-CLICaP) A Ruiz-Patiño, CD Castro, LM Ricaurte, AF Cardona, L Rojas, ... Targeted oncology 13 (5), 621-629, 2018 | 37 | 2018 |
| Cost-effectiveness of laparoscopic versus open appendectomy in developing nations: a Colombian analysis A Ruiz-Patiño, S Rey, G Molina, LC Dominguez, S Rugeles Journal of Surgical Research 224, 33-37, 2018 | 35 | 2018 |
| Systemic management of malignant meningiomas: A comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib AF Cardona, A Ruiz-Patiño, ZL Zatarain-Barrón, F Hakim, E Jiménez, ... PLoS One 14 (6), e0217340, 2019 | 31 | 2019 |
| Multigene mutation profiling and clinical characteristics of small-cell lung cancer in never-smokers vs. heavy smokers (Geno1. 3-CLICaP) AF Cardona, L Rojas, ZL Zatarain-Barron, A Ruiz-Patino, L Ricaurte, ... Frontiers in oncology 9, 254, 2019 | 31 | 2019 |
| Integration of artificial intelligence and precision oncology in Latin America L Sussman, JE Garcia-Robledo, C Ordóñez-Reyes, Y Forero, ... Frontiers in Medical Technology 4, 1007822, 2022 | 29 | 2022 |
| KRAS and MET in non-small-cell lung cancer: Two of the new kids on the ‘drivers’ block JE Garcia-Robledo, R Rosell, A Ruíz-Patiño, C Sotelo, O Arrieta, ... Therapeutic Advances in Respiratory Disease 16, 17534666211066064, 2022 | 23 | 2022 |
| Electronic nicotine delivery systems (ECs) and COVID-19: the perfect storm for young consumers LE Pino, I Triana, C Pérez, A Piotrostanalzki, A Ruiz-Patiño, G Lopes, ... Clinical and Translational Oncology 23 (1), 5-9, 2021 | 21 | 2021 |
| Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID‐19 pandemic: the THOCOoP cooperative group O Arrieta, AF Cardona, L Lara-Mejia, D Heredia, F Barron, ... Critical reviews in oncology/hematology 153, 103033, 2020 | 21 | 2020 |
| Lung cancer in Colombia AF Cardona, SA Mejía, L Viola, DF Chamorro, L Rojas, A Ruíz-Patiño, ... Journal of Thoracic Oncology 17 (8), 953-960, 2022 | 20 | 2022 |
| Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an … DF Chamorro, AF Cardona, J Rodríguez, A Ruiz-Patiño, O Arrieta, ... Targeted Oncology 18 (3), 425-440, 2023 | 19 | 2023 |
| DICER1-associated central nervous system sarcoma: A comprehensive clinical and genomic characterization of case series of young adult patients AF Cardona, DF Chamorro Ortiz, A Ruíz-Patiño, D Gomez, Á Muñoz, ... Neuro-oncology practice 10 (4), 381-390, 2023 | 18 | 2023 |
